Contribution of Tumor-Derived Extracellular Vesicles to Malignant Transformation of Normal Cells
- PMID: 35735488
- PMCID: PMC9220176
- DOI: 10.3390/bioengineering9060245
Contribution of Tumor-Derived Extracellular Vesicles to Malignant Transformation of Normal Cells
Abstract
Tumor-cell-derived extracellular vesicles (EVs) are known to carry biologically active molecules of parental cells, which can actively modulate the tumor microenvironment. EVs produced by tumor cells play significant roles in the development and maintenance of tumor growth, metastasis, immune escape, and other important processes. However, the ability of EVs to induce the transformation of normal cells has hardly been investigated. This review discusses studies that describe the ability of tumor-cell-derived EVs to alter the metabolism and morphology of normal cells, causing changes associated with malignant transformation. Additionally, the horizontal transfer of oncogenes through EVs of tumor cells and the induction of epigenetic changes in normal cells, which leads to genomic instability and subsequent oncogenic transformation of normal cells, are also discussed.
Keywords: carcinogenesis; extracellular vesicles; tumor heterogeneity; tumor microenvironment.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Barriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras.Oncotarget. 2016 Aug 9;7(32):51991-52002. doi: 10.18632/oncotarget.10627. Oncotarget. 2016. PMID: 27437771 Free PMC article.
-
Tumor-derived extracellular vesicles: The metastatic organotropism drivers.Life Sci. 2022 Jan 15;289:120216. doi: 10.1016/j.lfs.2021.120216. Epub 2021 Dec 7. Life Sci. 2022. PMID: 34890589 Review.
-
Extracellular vesicles in cancer diagnostics and therapeutics.Pharmacol Ther. 2021 Jul;223:107806. doi: 10.1016/j.pharmthera.2021.107806. Epub 2021 Jan 17. Pharmacol Ther. 2021. PMID: 33465400 Review.
-
Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical challenges.Stem Cell Res Ther. 2019 Nov 26;10(1):347. doi: 10.1186/s13287-019-1468-6. Stem Cell Res Ther. 2019. PMID: 31771657 Free PMC article. Review.
-
HPV-Related Cervical Cancer and Extracellular Vesicles.Diagnostics (Basel). 2022 Oct 25;12(11):2584. doi: 10.3390/diagnostics12112584. Diagnostics (Basel). 2022. PMID: 36359429 Free PMC article. Review.
Cited by
-
Cancer Bioenergetics and Tumor Microenvironments-Enhancing Chemotherapeutics and Targeting Resistant Niches through Nanosystems.Cancers (Basel). 2023 Jul 28;15(15):3836. doi: 10.3390/cancers15153836. Cancers (Basel). 2023. PMID: 37568652 Free PMC article. Review.
-
The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity.Int J Mol Sci. 2022 Dec 26;24(1):395. doi: 10.3390/ijms24010395. Int J Mol Sci. 2022. PMID: 36613838 Free PMC article. Review.
-
The Role of Extracellular Vesicles in the Pathogenesis of Hematological Malignancies: Interaction with Tumor Microenvironment; a Potential Biomarker and Targeted Therapy.Biomolecules. 2023 May 27;13(6):897. doi: 10.3390/biom13060897. Biomolecules. 2023. PMID: 37371477 Free PMC article. Review.
-
The role of exosomes in bladder cancer immunotherapy.J Natl Cancer Cent. 2025 May 2;5(3):252-266. doi: 10.1016/j.jncc.2025.04.001. eCollection 2025 Jun. J Natl Cancer Cent. 2025. PMID: 40693234 Free PMC article. Review.
-
Comparative Analysis of Natural and Cytochalasin B-Induced Membrane Vesicles from Tumor Cells and Mesenchymal Stem Cells.Curr Issues Mol Biol. 2022 Nov 1;44(11):5363-5378. doi: 10.3390/cimb44110363. Curr Issues Mol Biol. 2022. PMID: 36354675 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources